Stay updated on Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.

Latest updates to the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now indicates that recruitment has closed and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment label). It also removes the older 'Intervention / Treatment' label and the older 'Revision: v3.5.5' reference, signaling a minor reorganization and an updated page version.SummaryDifference0.4%

- Check18 days agoChange DetectedThe revision tag on the page updated from v3.5.4 to v3.5.5. This reflects a new version in the underlying system and does not indicate changes to the visible content.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page shows a new revision label, updating from v3.5.3 to v3.5.4. This represents an administrative version update to the study documentation rather than a substantive change to the study details.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a site/version update without changing the study details.SummaryDifference0.1%

- Check68 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Small cell lung carcinoma as a topic and added a new 'Genetic and Rare Diseases Information Center' resource under Resources.SummaryDifference0.2%

Stay in the know with updates to Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.